ICOSLG and breast cancer: To differentiate between these two forms, we selectively overexpressed sIcosl (lacking the transmembrane domain and equipped with a signal peptide) and mIcosl (with mutations in the shedding site) in the Icosl-KO breast cancer cell lines.